|
SDZ 21009,β-肾上腺素受体拮抗剂
|
S288286-50mg
|
|
39731-05-0 |
50mg
|
¥ 6850.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SDZ 21009,β-肾上腺素受体拮抗剂
|
S288286-10mg
|
|
39731-05-0 |
10mg
|
¥ 1669.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SMANT hydrochloride,抑制平滑(Smo)积累
|
S288275-50mg
|
≥99%(HPLC) |
1177600-74-6 |
50mg
|
¥ 3418.9
|
现货 |
|
0 |
阿拉丁 |
|
SMANT hydrochloride,抑制平滑(Smo)积累
|
S288275-10mg
|
≥99%(HPLC) |
1177600-74-6 |
10mg
|
¥ 988.9
|
现货 |
|
0 |
阿拉丁 |
|
Senexin A,Cdk8抑制剂
|
S288272-10mg
|
≥98%(HPLC) |
1780390-76-2 |
10mg
|
¥ 2452.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SB 747651A 二盐酸盐
|
S288267-10mg
|
≥98% |
1781882-72-1 |
10mg
|
¥ 2599.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
ShK-Dap22,极KV1.3阻滞剂
|
S288250-100μg
|
|
220384-25-8 |
100μg
|
¥ 3018.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SGC AAK1 1,AAK1和BMP2K抑制剂
|
S288249-5mg
|
≥98%(HPLC) |
2247894-32-0 |
5mg
|
¥ 143.9
|
现货 |
|
0 |
阿拉丁 |
|
SGC AAK1 1,AAK1和BMP2K抑制剂
|
S288249-25mg
|
≥98%(HPLC) |
2247894-32-0 |
25mg
|
¥ 440.9
|
现货 |
|
0 |
阿拉丁 |
|
SW 033291,15-PGDH抑制剂
|
S288218-50mg
|
≥98%(HPLC) |
459147-39-8 |
50mg
|
¥ 4325.9
|
现货 |
|
0 |
阿拉丁 |
|
SW 033291,15-PGDH抑制剂
|
S288218-10mg
|
≥98%(HPLC) |
459147-39-8 |
10mg
|
¥ 1111.9
|
现货 |
|
0 |
阿拉丁 |
|
SPP 86,RET抑制剂
|
S288209-50mg
|
≥98%(HPLC) |
1357349-91-7 |
50mg
|
¥ 2776.9
|
现货 |
|
0 |
阿拉丁 |
|
SPP 86,RET抑制剂
|
S288209-10mg
|
≥98%(HPLC) |
1357349-91-7 |
10mg
|
¥ 1899.9
|
现货 |
|
0 |
阿拉丁 |
|
(S)-克罗替尼
|
S288194-50mg
|
Moligand™, ≥98% |
1374356-45-2 |
50mg
|
¥ 2041.9
|
现货 |
|
0 |
阿拉丁 |
|
(S)-克罗替尼
|
S288194-10mg
|
Moligand™, ≥98% |
1374356-45-2 |
10mg
|
¥ 835.9
|
现货 |
|
0 |
阿拉丁 |
|
SB 706375,非肽类UT受体拮抗剂
|
S288183-50mg
|
Moligand™, ≥98%(HPLC) |
733734-61-7 |
50mg
|
¥ 6932.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SB 706375,非肽类UT受体拮抗剂
|
S288183-10mg
|
Moligand™, ≥98%(HPLC) |
733734-61-7 |
10mg
|
¥ 1906.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SKF 38393 氢溴酸盐
|
S288170-100mg
|
≥98%(HPLC) |
20012-10-6 |
100mg
|
¥ 2569.9
|
现货 |
|
0 |
阿拉丁 |
|
SJFδ
|
S288160-5mg
|
≥98%(HPLC) |
2254609-23-7 |
5mg
|
¥ 8625.9
|
现货 |
|
0 |
阿拉丁 |
|
SHIP 2a,半胱氨酸γ裂解酶(CSE)抑制剂
|
S288158-50mg
|
≥98%(HPLC) |
2165706-30-7 |
50mg
|
¥ 7198.9
|
现货 |
|
0 |
阿拉丁 |
|
SHIP 2a,半胱氨酸γ裂解酶(CSE)抑制剂
|
S288158-10mg
|
≥98%(HPLC) |
2165706-30-7 |
10mg
|
¥ 1999.9
|
现货 |
|
0 |
阿拉丁 |
|
SC 19220,EP1受体拮抗剂
|
S288147-50mg
|
Moligand™, ≥99%(HPLC) |
19395-87-0 |
50mg
|
¥ 8014.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SC 19220,EP1受体拮抗剂
|
S288147-10mg
|
Moligand™, ≥99%(HPLC) |
19395-87-0 |
10mg
|
¥ 1906.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
沙卡布曲 钙盐
|
S288144-50mg
|
≥98%(HPLC) |
1369773-39-6 |
50mg
|
¥ 268.9
|
现货 |
|
0 |
阿拉丁 |